Friedrich M - Search Results

1

An altered miTRAP method for miRNA affinity purification with its pros and cons.

Jasinski-Bergner S, Vaxevanis C, Heimer N, Lazaridou MF, Friedrich M, Seliger B. Jasinski-Bergner S, et al. Among authors: friedrich m. Methods Enzymol. 2020;636:323-337. doi: 10.1016/bs.mie.2019.05.016. Epub 2019 Jun 8. Methods Enzymol. 2020. PMID: 32178824

2

The role of the miR-148/-152 family in physiology and disease.

Friedrich M, Pracht K, Mashreghi MF, Jäck HM, Radbruch A, Seliger B. Friedrich M, et al. Eur J Immunol. 2017 Dec;47(12):2026-2038. doi: 10.1002/eji.201747132. Epub 2017 Sep 29. Eur J Immunol. 2017. PMID: 28880997 Free article. Review.

3

Identification of Immune Modulatory miRNAs by miRNA Enrichment via RNA Affinity Purification.

Tretbar US, Friedrich M, Lazaridou MF, Seliger B. Tretbar US, et al. Among authors: friedrich m. Methods Mol Biol. 2019;1913:81-101. doi: 10.1007/978-1-4939-8979-9_6. Methods Mol Biol. 2019. PMID: 30666600

4

TGF-β inducible epithelial-to-mesenchymal transition in renal cell carcinoma.

Tretbar S, Krausbeck P, Müller A, Friedrich M, Vaxevanis C, Bukur J, Jasinski-Bergner S, Seliger B. Tretbar S, et al. Among authors: friedrich m. Oncotarget. 2019 Feb 19;10(15):1507-1524. doi: 10.18632/oncotarget.26682. eCollection 2019 Feb 19. Oncotarget. 2019. PMID: 30863498 Free PMC article.

5

Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy.

Friedrich M, Jasinski-Bergner S, Lazaridou MF, Subbarayan K, Massa C, Tretbar S, Mueller A, Handke D, Biehl K, Bukur J, Donia M, Mandelboim O, Seliger B. Friedrich M, et al. Cancer Immunol Immunother. 2019 Oct;68(10):1689-1700. doi: 10.1007/s00262-019-02373-1. Epub 2019 Aug 3. Cancer Immunol Immunother. 2019. PMID: 31375885 Free PMC article. Review.

6

Identification of immunomodulatory RNA-binding proteins in tumors.

Friedrich M, Lazaridou MF, Rahn J, Vaxevanis C, Heimer N, Jasinski-Bergner S, Seliger B. Friedrich M, et al. Methods Enzymol. 2020;636:339-350. doi: 10.1016/bs.mie.2019.05.042. Epub 2019 Jun 17. Methods Enzymol. 2020. PMID: 32178825

7

CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma.

Friedrich M, Heimer N, Stoehr C, Steven A, Wach S, Taubert H, Hartmann A, Seliger B. Friedrich M, et al. Sci Rep. 2020 Apr 16;10(1):6499. doi: 10.1038/s41598-020-63403-y. Sci Rep. 2020. PMID: 32300145 Free PMC article.

8

What turns CREB on? And off? And why does it matter?

Steven A, Friedrich M, Jank P, Heimer N, Budczies J, Denkert C, Seliger B. Steven A, et al. Among authors: friedrich m. Cell Mol Life Sci. 2020 Oct;77(20):4049-4067. doi: 10.1007/s00018-020-03525-8. Epub 2020 Apr 28. Cell Mol Life Sci. 2020. PMID: 32347317 Free PMC article. Review.

9

Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744.

Friedrich M, Vaxevanis CK, Biehl K, Mueller A, Seliger B. Friedrich M, et al. J Immunother Cancer. 2020 Jun;8(1):e000396. doi: 10.1136/jitc-2019-000396. J Immunother Cancer. 2020. PMID: 32571994 Free PMC article.

10

Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma.

Lazaridou MF, Massa C, Handke D, Mueller A, Friedrich M, Subbarayan K, Tretbar S, Dummer R, Koelblinger P, Seliger B. Lazaridou MF, et al. Among authors: friedrich m. J Clin Med. 2020 Aug 20;9(9):2690. doi: 10.3390/jcm9092690. J Clin Med. 2020. PMID: 32825219 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,916 results

Search Page